Download PDF

1. Company Snapshot

1.a. Company Description

Amplifon S.p.A. retails hearing care products and services that help people rediscover various emotions of sound.The company offers ampli-easy, ampli-mini, ampli-connect, and ampli-energy hearing devices.It also provides fitting of customized products.


As of March 18, 2022, the company operated a network of approximately 9,200 points of sale in 25 countries and 5 continents.The company also sells its products through 1,350 franchisees.It has operations in Europe, the Middle East, Africa, the United States, Asia, and Oceania.


The company was founded in 1950 and is headquartered in Milan, Italy.

Show Full description

1.b. Last Insights on AMP

Amplifon's recent performance was negatively impacted by concerns over its acquisition of GN Hearing, with investors worried about the high price paid to address slowing growth. The company's 2025 earnings report showed sales of €2,395.7 million and net income of €91.3 million, but a reset in expectations. The sale of its loss-making UK business and positive organic growth were overshadowed by FX headwinds and market challenges. The $2.6 billion deal to acquire GN Hearing, expected to complete by end-2026, aims to create a vertically integrated audiology group.

1.c. Company Highlights

2. Amplifon Delivers Mixed FY2025 Results Amidst Challenging Market Conditions

Amplifon reported revenues of EUR 2.4 billion, up 1.7% at constant FX, and adjusted EBITDA of EUR 540 million, with a margin of 22.6%. However, EPS came in at EUR 0.1556, significantly lower than analyst estimates of EUR 0.3018. The company's net financial debt stood at slightly above EUR 1 billion, and adjusted free cash flow was EUR 174 million. The stock's current valuation metrics, including a P/E Ratio of 23.06 and an EV/EBITDA of 8.07, indicate a relatively high multiple, suggesting that the market has already priced in significant growth expectations.

Publication Date: Mar -05

📋 Highlights
  • Revenue & EBITDA Growth:: Revenues rose 1.7% to EUR 2.4B (constant FX), adjusted EBITDA reached EUR 540M with a 22.6% margin, driven by organic growth and FX-neutral performance.
  • Fit4Growth Cost Savings:: EUR 30M CapEx reduction in 2025; program targets 150-200 bps EBITDA margin improvement by 2027, with EUR 25M non-recurring costs in 2025.
  • Market Outperformance:: Organic growth of 0.6% in Q4, outperforming in Italy, US, Australia, and France despite a 1-2% global demand rise and softer US market.
  • Sustainability Achievements:: 14% emissions reduction, 83% renewable energy usage, and 600,000 employee training hours, earning Global Top Employer 2026 Certification.
  • 2026 Outlook:: Anticipates 3% market growth, margin expansion from Fit4Growth, and strategic M&A restart in the US to offset UK divestiture impacts, with no loss of market share in key regions.

Regional Performance and Market Outlook

Despite a challenging market environment, Amplifon outperformed the market in key countries like Italy, the US, Australia, and France. The company's sales increased by 1.4% at constant exchange rates in Q4, driven by positive organic growth across all regions. Enrico Vita, Amplifon's management, noted that the company expects a gradual normalization of market growth in Europe and a recovery in the US in 2026. The company's guidance for 2026 is qualitative, with expectations of revenue growth driven by better market conditions and marketing investments.

Fit4Growth Program and Profitability

The Fit4Growth program, launched to enhance profitability, is progressing well and is expected to deliver tangible results in 2026. The program aims to improve adjusted EBITDA margin by 150-200 basis points by 2027, with non-recurring cash costs estimated at EUR 25 million. Amplifon's management expects a significant contribution from the Fit4Growth program in 2026, with a focus on network efficiency, back-office efficiency, cost containment, and strategic review of business segments.

Valuation and Growth Expectations

Analysts estimate next year's revenue growth at 6.1%, which is higher than the company's historical growth rate. Given the current valuation metrics, it appears that the market has already priced in significant growth expectations. The stock's P/S Ratio of 1.11 and ROE of 10.82% suggest a relatively attractive valuation. However, the Net Debt / EBITDA ratio of 3.09 indicates a relatively high level of indebtedness, which may impact the company's ability to invest in growth initiatives.

Outlook and Conclusion

Amplifon's management is confident in its ability to outperform the market, citing examples such as Australia, where it posted positive organic growth despite a negative market, and France, where it performed better than the market in terms of units. The company's expectations of 3% market growth in 2026 are considered a fair assumption, taking into account the current macroeconomic and geopolitical environment. Overall, Amplifon's mixed FY2025 results and guidance for 2026 suggest a challenging but potentially rewarding investment opportunity.

3. NewsRoom

Card image cap

AMPLIFON INVESTS IN AUDIOLOGICAL RESEARCH AND INNOVATION WITH THE APPOINTMENT OF DR. NICHOLAS REED AS VP AUDIOLOGY INNOVATION & RESEARCH

Mar -31

Source:

Card image cap

Amplifon GN Hearing Deal Reshapes Valuation And Growth Outlook

Mar -18

Source:

Card image cap

Amplifon’s Big Bet Has Investors Hearing Alarm Bells

Mar -17

Source:

Card image cap

Amplifon to acquire GN Hearing in $2.6bn deal

Mar -17

Source:

Card image cap

Amplifon to Buy GN Store Nord Hearing-Aid Unit in $2.6 Billion Deal

Mar -16

Source:

Card image cap

GN Store Nord A/S enters into agreement to sell its Hearing business to Amplifon S.p.A. for DKK 17.0 billion

Mar -16

Source:

Card image cap

A Look At Amplifon (BIT:AMP) Valuation After 2025 Earnings Reset And Fit4Growth Margin Plan

Mar -07

Source:

Card image cap

Amplifon SpA (AMFPF) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...

Mar -05

Source:

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (8.83%)

6. Segments

Hearing Solutions

Expected Growth: 8.9%

Amplifon's 8.9% growth in Hearing Solutions is driven by increasing demand for hearing aids, expansion into emerging markets, and strategic acquisitions. Additionally, the company's focus on innovative products, such as AI-powered hearing aids, and its strong distribution network contribute to its growth momentum.

Services

Expected Growth: 8.37%

Amplifon's 8.37% growth is driven by increasing demand for hearing solutions, expansion into emerging markets, and strategic acquisitions. The company's focus on innovative products and services, such as artificial intelligence-powered hearing aids, also contributes to growth. Additionally, Amplifon's strong distribution network and partnerships with healthcare providers enable the company to reach a wider customer base.

7. Detailed Products

Hearing Aids

Amplifon offers a wide range of hearing aids from leading manufacturers, including Phonak, Oticon, and Widex. These devices are designed to improve hearing and communication for individuals with hearing loss.

Hearing Tests and Diagnostics

Amplifon provides comprehensive hearing tests and diagnostics to identify hearing loss and determine the best course of treatment.

Audiology Services

Amplifon's team of audiologists provides personalized audiology services, including hearing aid fittings, adjustments, and maintenance.

Hearing Protection

Amplifon offers custom-made hearing protection solutions for individuals working in noisy environments or participating in loud recreational activities.

Tinnitus Management

Amplifon provides tinnitus management solutions, including sound therapy and counseling, to help individuals cope with tinnitus symptoms.

8. Amplifon S.p.A.'s Porter Forces

Forces Ranking

Threat Of Substitutes

The threat of substitutes for Amplifon S.p.A. is medium due to the presence of alternative products and services in the hearing care industry.

Bargaining Power Of Customers

The bargaining power of customers for Amplifon S.p.A. is low due to the company's strong brand reputation and customer loyalty.

Bargaining Power Of Suppliers

The bargaining power of suppliers for Amplifon S.p.A. is medium due to the presence of multiple suppliers in the market.

Threat Of New Entrants

The threat of new entrants for Amplifon S.p.A. is low due to the high barriers to entry in the hearing care industry.

Intensity Of Rivalry

The intensity of rivalry for Amplifon S.p.A. is high due to the presence of several competitors in the hearing care industry.

9. SWOT Analysis

Strength

Weaknesses

Opportunities

Threats

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 50.88%
Debt Cost 3.96%
Equity Weight 49.12%
Equity Cost 7.68%
WACC 5.79%
Leverage 103.57%

11. Quality Control: Amplifon S.p.A. passed 3 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
ConvaTec

A-Score: 4.8/10

Value: 2.8

Growth: 5.3

Quality: 6.0

Yield: 3.1

Momentum: 5.0

Volatility: 6.3

1-Year Total Return ->

View Full Report
Stock-Card
Ypsomed

A-Score: 4.1/10

Value: 2.6

Growth: 8.2

Quality: 5.7

Yield: 0.6

Momentum: 3.0

Volatility: 4.3

1-Year Total Return ->

View Full Report
Stock-Card
Tecan

A-Score: 3.9/10

Value: 4.9

Growth: 4.1

Quality: 6.1

Yield: 2.5

Momentum: 1.0

Volatility: 4.7

1-Year Total Return ->

View Full Report
Stock-Card
Carl Zeiss Meditec

A-Score: 3.4/10

Value: 4.0

Growth: 5.1

Quality: 5.7

Yield: 1.9

Momentum: 1.5

Volatility: 2.3

1-Year Total Return ->

View Full Report
Stock-Card
Elekta

A-Score: 3.4/10

Value: 3.8

Growth: 4.0

Quality: 3.2

Yield: 6.9

Momentum: 1.0

Volatility: 1.7

1-Year Total Return ->

View Full Report
Stock-Card
Amplifon

A-Score: 3.4/10

Value: 5.0

Growth: 5.4

Quality: 4.7

Yield: 2.5

Momentum: 0.0

Volatility: 2.7

1-Year Total Return ->

View Full Report

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

9.93$

Current Price

9.93$

Potential

-0.00%

Expected Cash-Flows